Oneness Biotech Co., Ltd. (TPEX:4743)
55.60
-0.50 (-0.89%)
Dec 31, 2025, 2:31 PM CST
Oneness Biotech Market Cap
Oneness Biotech has a market cap or net worth of 26.6 billion as of December 31, 2025. Its market cap has decreased by -45.11% in one year.
Market Cap
26.60B
Enterprise Value
21.58B
Revenue
117.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
55.60
Market Cap Chart
Since June 22, 2009, Oneness Biotech's market cap has increased from 1.24B to 26.60B, an increase of 2,045.62%. That is a compound annual growth rate of 20.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 26.60B | -36.18% |
| Dec 31, 2024 | 41.68B | -52.65% |
| Dec 29, 2023 | 88.03B | -7.55% |
| Dec 30, 2022 | 95.22B | -13.04% |
| Dec 30, 2021 | 109.49B | 21.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 250.47B |
| PharmaEssentia | 179.19B |
| Lotus Pharmaceutical | 74.95B |
| Heron Neutron Medical | 70.34B |
| Bora Pharmaceuticals Co., LTD. | 61.64B |
| Lin BioScience | 32.06B |
| Lumosa Therapeutics | 31.92B |
| Center Laboratories | 29.26B |